Skip to content

Hannah Chesser, M.D.

NPI 1104204767ActiveIndividual· Pediatrics, Pediatric Endocrinology· San Francisco, CA

Pediatrics, Pediatric Endocrinology (M.D.) in San Francisco, California, licensed in CA, with an NPI issued in May 2015. Part D covered 13 prescriptions written in 2024. Azurity Pharmaceuticals, Inc. reported $18.54 in payments in 2025, mostly food and beverage.

Overview

NPI1104204767
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedMay 14, 2015
Last updated in NPPESAug 12, 2021
Certified by providerAug 12, 2021

Specialties and licenses

TaxonomyCodeLicenseState
Pediatrics, Pediatric Endocrinology Primary2080P0205XA154814CA

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (CA)

Part D prescriptions in 2024

Prescriptions (claims)13 · 13 30-day fills
Total drug cost$61.55

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$18.54 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Azurity Pharmaceuticals, Inc.$18.541

What the 2025 payments were for

  • Food and Beverage$18.54 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Pediatrics, Pediatric Endocrinology providers in San Francisco

All 19 Pediatrics, Pediatric Endocrinology providers in San Francisco · All Pediatrics, Pediatric Endocrinology providers in California